Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Maternal serum CA 125 levels in first trimester abortion

I Noci1, R Biagiotti, E Periti

  • 1Department of Gynaecology and Obstetrics, University of Florence, Italy.

European Journal of Obstetrics, Gynecology, and Reproductive Biology
|May 1, 1995
PubMed
Summary

Maternal serum CA 125 levels increase in non-viable pregnancies only when there is decidual disruption and vaginal bleeding. This suggests the decidua is the primary source of CA 125 in early pregnancy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

On color adjustment potential and color blending threshold of dental composite resins.

Journal of esthetic and restorative dentistry : official publication of the American Academy of Esthetic Dentistry ... [et al.]·2024
Same author

Spatially resolved, high-dimensional transcriptomics sorts out the evolution of biphasic malignant pleural mesothelioma: new paradigms for immunotherapy.

Molecular cancer·2023
Same author

Brillouin-Raman microspectroscopy for the morpho-mechanical imaging of human lamellar bone.

Journal of the Royal Society, Interface·2022
Same author

Draft Genome Sequence of Clostridium difficile Belonging to Ribotype 018 and Sequence Type 17.

Genome announcements·2016
Same author

Anti-HMGCR antibody-associated necrotizing myopathy: diagnosis and treatment illustrated using a case report.

Scandinavian journal of rheumatology·2016
Same author

Automated urinalysis with expert review for incidental identification of atypical urothelial cells: An anticipated bladder carcinoma diagnosis.

Clinica chimica acta; international journal of clinical chemistry·2015

Area of Science:

  • Reproductive biology
  • Maternal-fetal medicine
  • Biochemistry

Background:

  • CA 125 is a tumor marker often elevated in gynecological conditions.
  • Its role in early pregnancy, particularly in non-viable gestations, is not fully understood.
  • Decidual cells are known to produce various proteins during pregnancy.

Purpose of the Study:

  • To investigate the origin of elevated maternal serum CA 125 in the first trimester of pregnancy.
  • To determine if CA 125 levels correlate with pregnancy viability and decidual integrity.
  • To explore the decidua as a potential source of serum CA 125.

Main Methods:

  • CA 125 levels were measured in serum samples from first-trimester pregnancies (8-13 weeks).
  • Samples were from non-viable pregnancies, categorized by the presence (n=19) or absence (n=13) of vaginal bleeding.

Related Experiment Videos

  • Only pregnancies with normal karyotypes were included; CA 125 was expressed as multiples of the median (MoM).

    • Main Results:

    • Significantly higher CA 125 levels (1.81 MoM) were observed in women with vaginal bleeding compared to non-bleeders (0.82 MoM) and normal pregnancies (1.01 MoM).
    • No significant difference in CA 125 levels was found between non-bleeding women and controls.
    • Elevated CA 125 was specifically associated with decidual disruption indicated by vaginal bleeding.

    Conclusions:

    • Increased maternal serum CA 125 in non-viable, euploid pregnancies is linked to decidual disruption and vaginal bleeding.
    • These findings support the decidua as the predominant source of serum CA 125 during early pregnancy.
    • Decidual integrity plays a crucial role in regulating CA 125 levels in maternal circulation.